Jose De Andres

Jose De Andres

Auto-generated profile, based on publicly available information

Jose De Andres

Department of Anesthesiology, Critical Care and Pain Management, Hospital General Universitario de Valencia, Valencia, Spain

Research Focus & Metrics

Academic Career Length

26Years (2001-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 June 2019 in Korean Journal of Anesthesiology
Verified
Journal Article
Open access
PDF file
PKPablo Kot
Pablo Kot
PRPablo Rodriguez
Pablo Rodriguez
Manuel GranellManuel Granell
Manuel Granell
BCBeatriz Cano
Beatriz Cano
LSLucas Rovira Soriano
Lucas Rovira Soriano
JAJose De Andrés
Jose De Andrés
Regional anesthesia and pain management have experienced advances in recent years, especially with the advent of fascial plane blocks. The erector spinae plane block is one of the newest techniques to be described. In the past two years, publications referring to ESP block have increased significantly. The objective of this review is to analyze the articles about ESP block that have been published to date. We performed a search in the main databases and identified 368 articles. After a selection of the relevant articles, 125 studies were found eligible and were included in the review. The ESP block is performed by depositing the local anesthetic in the fascial plane, deeper than the erector spinae muscle at the tip of the transverse process of the vertebra. Many cases of its use have been described with satisfactory results in the treatment of both acute pain and chronic pain. The applicability of the technique covers many clinical scenarios. Of the 98 case reports reviewed, 12 and 87 articles, respectively described the technique as a treatment for chronic pain and acute pain. The single-shot was the most frequently used technique. As described in the articles published to date, the technique is easy to perform and has a low rate of complications. However, despite the effectiveness of the technique, further studies are necessary to obtain more evidence of its actions.

4 November 2017 in Pain Medicine
Verified
Journal Article
Open access
PDF file
JAJose De Andres
Jose De Andres
VMVicente Monsalve-Dolz
Vicente Monsalve-Dolz
GFGustavo Fabregat
Gustavo Fabregat
VVVicente Villanueva-Perez
Vicente Villanueva-Perez
AHAnushik Harutyunyan
Anushik Harutyunyan
NSNerea Sanchis-Lopez
Nerea Sanchis-Lopez
Spinal cord stimulation (SCS) for patients with failed back surgery syndrome (FBSS) show variable results and limited to moderate evidence. In the last years the stimulation of high frequency (HF) has been considered as a better alternative in this pathology for its supposed benefits compared to the stimulation with conventional frequency (CF). To compare in one year follow-up, the efficacy of high-frequency SCS (HF) versus conventional frequency SCS (CF) on the patients with FBSS. Prospective, Randomized blind trial. Academic University Pain Medicine Center. Seventy eight patients with FBSS diagnosis based on internationally recognized criteria, and refractory to conservative therapy for at least 6 months, have been initially recruited, and Sixty subjects met the eligibility criteria and were randomized and scheduled for the trial phase.The patients were randomly assigned in either, one of the two groups: CF SCS or HF SCS. Within the study methods, special attention was paid to standardizing patient programming, so that these parameters would not impact the results.The trial period was considered successful if there was ?50% reduction in the NRS from baseline. A total of 55 subjects successfully completed all assessments during one year follow-up. Change patterns in scores do not differ based on high versus conventional frequency, with significant global average reduction at 1 year similarly for both groups. Among all the items included in the Short Form-12 questionnaire (SF-12), only the variations in the social function score between the instants t1 and t2 are somewhat higher in the high frequency group. The evolutionary pattern of the different parameters studied in our patients with FBSS does not differ according to their treatment by spinal stimulation, with conventional or high frequency, in one year follow-up.

14 May 2020 in Psychological Medicine
Verified
Journal Article
Open access
PDF file
Carolina Soledad Romero GarciaCarolina Soledad Romero Garcia
Carolina Soledad Romero Garcia
JCJuan Catalá
Juan Catalá
CDCarlos Delgado
Carlos Delgado
CFCarolina Ferrer
Carolina Ferrer
CECarlos Errando
Carlos Errando
MOMaria Otero
Maria Otero
Background: The current coronavirus disease (COVID-19) has a great impact worldwide. Healthcare workers play an essential role and are one of the most exposed groups. Information about the psychosocial impact on healthcare workers is limited.Methods: 3109 healthcare workers completed a national, internet-based, cross-sectional 45-item survey between 9 and 19 April 2020. The objective is to assess the psychological impact of the COVID-19 pandemic in Spanish healthcare workers. A Psychological Stress and Adaptation at work Score (PSAS) was defined combining four modified versions of validated psychological assessment tests (A) Healthcare Stressful Test, (B) Coping Strategies Inventory, (C) Font-Roja Questionnaire and (D) Trait Meta-Mood Scale.Results: The highest psychosocial impact was perceived in Respiratory Medicine, the mean (S.D.) PSAS was 48.3 (13.6) and Geriatrics 47.6 (16.4). Higher distress levels were found in the geographical areas with the highest incidence of COVID-19 (>245.5 cases per 100 000 people), PSAS 46.8 (15.2); p < 0.001. The least stress respondents were asymptomatic workers PSAS, 41.3 (15.4); p < 0.001, as well as those above 60 years old, PSAS, 37.6 (16); p < 0.001. Workers who needed psychological therapy and did not receive it, were more stressed PSAS 52.5 (13.6) than those who did not need it PSAS 39.7 (13.9); p < 0.001.Conclusions: The psychological impact in healthcare workers in Spain during COVID-19 emergency has been studied. The stress perceived is parallel to the number of cases per 100 000 people. Psychotherapy could have a major role to mitigate the experimented stress level.

1 March 2012 in The Clinical Journal of Pain
Verified
Journal Article
Closed access
JAJose MD De Andrés
Jose MD De Andrés
JPJuan Pérez-Cajaraville
Juan Pérez-Cajaraville
MLMaria Dolores Lopez-Alarcón
Maria Dolores Lopez-Alarcón
JLJose Manuel Lopez-Millan
Jose Manuel Lopez-Millan
CMCesar Margarit
Cesar Margarit
MPMaría Pérez
María Pérez
Objective: The aim of this study was to culturally adapt into Spanish and validate the painDETECT questionnaire, a brief self-administered instrument designed to screen the presence of a neuropathic pain component in usual clinical practice. Methods: The original English painDETECT questionnaire was culturally adapted into Spanish (Spain) by 2 independent translators under supervision of an expert panel. The LANNS, and a pain visual analog scale were administered along with the painDETECT questionnaire to a sample of 252 patients with neuropathic, nociceptive, or mixed pain for at least 3 months. Patients were classified by experienced specialists under normal conditions of clinical practice. A retest measure after 24 to 48 hours was also carried out. Reliability, construct validity, convergent validity, criterion, and discriminant validity were assessed. Results: An effective sample of 221 patients with chronic pain was recruited, 32% diagnosed of neuropathic origin, 32% of nociceptive, and remaining 36% presented mixed pain. The average age was 57.8 years (SD=14.2) and 59% were women. Cronbach alpha attained a value of 0.86, and the intraclass correlation coefficient with the retest was 0.93. The factor structure was coherent with the one informed for the original instrument. Pearson correlation with the LANSS scale was 0.88. Area under the receiver operating characteristic curve was 0.88 when comparing neuropathic and nociceptive groups. Using the suggested cutoff value for pain presence of 19 points or higher, the following discriminant values are obtained: sensitivity=75%, specificity=84%, Youden Index=0.595, positive predictive value=92%, and negative predictive value=60%. The absence cutoff value of 12 points or bellow raised the following values: sensitivity=93%, specificity=68%, Youden Index=0.61, positive predictive value=87%, and negative predictive value=80%. When mixed pain patients are included in the group with a neuropathic component, discriminant values are slightly reduced, as expected. Conclusions: The culturally adapted version of the painDETECT presents good psychometric properties and shows to be a valid patient-reported outcome for measuring the presence of a neuropathic component in patients with chronic pain.

12 January 2015 in Pain Practice
Verified
Journal Article
Closed access
PDF file
JAJose De Andres
Jose De Andres
NSNerea Sanchis‐Lopez
Nerea Sanchis‐Lopez
JAJuan Marcos Asensio‐Samper
Juan Marcos Asensio‐Samper
GFGustavo Fabregat
Gustavo Fabregat
VVVicente L. Villanueva‐Perez
Vicente L. Villanueva‐Perez
AMAna Minguez
Ana Minguez

16 June 2022 in Frontiers in Pain Research
Verified
Journal Article
Open access
JAJose De Andres
Jose De Andres
SHSalim Hayek
Salim Hayek
CPChristophe Perruchoud
Christophe Perruchoud
MLMelinda M. Lawrence
Melinda M. Lawrence
MRMiguel Angel Reina
Miguel Angel Reina
TYTony L. Yaksh
Tony L. Yaksh
Advances in our understanding of the biology of spinal systems in organizing and defining the content of exteroceptive information upon which higher centers define the state of the organism and its role in the regulation of somatic and automatic output, defining the motor response of the organism, along with the unique biology and spatial organization of this space, have resulted in an increased focus on therapeutics targeted at this extracranial neuraxial space. Intrathecal (IT) drug delivery systems (IDDS) are well-established as an effective therapeutic approach to patients with chronic non-malignant or malignant pain and as a tool for management of patients with severe spasticity and to deliver therapeutics that address a myriad of spinal pathologies. The risk to benefit ratio of IDD makes it a useful interventional approach. While not without risks, this approach has a significant therapeutic safety margin when employed using drugs with a validated safety profile and by skilled practioners. The present review addresses current advances in our understanding of the biology and dynamics of the intrathecal space, therapeutic platforms, novel therapeutics, delivery technology, issues of safety and rational implementation of its therapy, with a particular emphasis upon the management of pain.